Atorvastatin — Drug Intelligence | 35 EU Trials

Filter these 35 trials by condition, phase, country and more.

Open in Search →

35 Registered trials

17 Recruiting

9 Completed trials

25 Sponsors

26 Countries

Phase III

Phase II

Phase IV

Phase III: 10 Phase II: 9 Phase III/IV: 2 Phase IV: 14

Oversight events:

1 serious breach across 1 trial

View oversight register →

Indications tested

Acute coronary syndrome 3 Ovarian cancer metastatic 1 Chronic obstructive pulmonary disease 1 Hypercholesterolaemia 1 Triple negative breast cancer 1 Cholelithiasis obstructive 1 Prostate cancer metastatic 1 Cholelithiasis 1 Dyslipidaemia 1 Primary hypercholesterolaemia 1 Breast cancer metastatic 1 Coronary artery disease 1

Sponsors using this IMP

Novartis Pharma AG 4 St. Olavs Hospital HF 4 Fundacion Epic 2 Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz 2 Pirkanmaan hyvinvointialue 2 Region Midtjylland 2 Akershus University Hospital 1 Amsterdam UMC 1 Amsterdam UMC Stichting 1 Centro Cardiologico Monzino S.p.A. 1 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 1 Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1

All trials

35 total

SAFEST Not authorised

2022-502059-79-00 Phase IV 1 country Amsterdam UMC
Atorvastatin in episodic migraine Not authorised

2022-502176-23-00 Phase II 1 country St. Olavs Hospital HF
Atorvastatin in chronic migraine (StainMigChronic) Not authorised

2022-502177-42-01 Phase II 1 country St. Olavs Hospital HF
Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) with Atorvastatin (ATORGO) Pending

2023-504654-35-00 Phase II 1 country Region Skane
Studies to gain insight how the drugs PCSK9-inhibitors and statins affect cholesterol and bile acid metabolism Pending

2023-505726-34-02 Phase IV 1 country Karolinska University Hospital
Statins to Prevent Immune checkpoint inhibitor-induced pRogression of AtheroscLerosis Pending

2024-511127-33-00 Phase IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Reassessment of statin-associated muscle symptoms in adults with familial hypercholesterolemia Pending

2025-521589-83-00 Phase IV 1 country Oslo University Hospital HF
Cholesterol lowering with atorvastatine for the prevention of gallstones following bariatric surgery: an investigator- blinded randomised co… Pending

2025-524191-38-00 Phase IV 1 country Spaarne Gasthuis Stichting
Combined impact of cardiovascular polypill treatment and a specific nurse education program on adherence to therapy in patients with ACS: a … Pending

2025-524751-32-00 Phase IV 1 country Fundacion Epic
CROSS-OVER ANALYSIS OF THE CONTROL OF RISK FACTORS AND ANTIAGGREGATION WITH POLIPILL (POLICROSS TRIAL) Recruiting

2024-518705-18-00 Phase III/IV 1 country Fundacion Epic
Repurposing statins as adjuvants for cancer patients receiving therapy with immune checkpoint inhibitors: the STARK trial Recruiting

2024-518500-47-00 Phase II 1 country Universita Degli Studi Di Padova
Evaluation of efficacy and safety of early in hospital initiation of inclisiran treatment in patients with acute coronary syndromes Recruiting

2025-521670-34-00 Phase III 5 countries Novartis Pharma AG
EUROpean pragmatic multicenter randomized trial on platelet inhibition and/or lipid lowering treatment in Covert Brain Infarction (CBI) Recruiting

2025-521452-30-01 Phase III 1 country Region Midtjylland
Treatment of Bile Acid Diarrhoea with Atorvastatin (BASTA) Recruiting

2025-521856-47-00 Phase III/IV 1 country Gentofte Hospital
Atorvastatinbehandling til patienter med de Philadelphia-negative kronisk myeloproliferative neoplasier - essentiel trombocytose, polycythem… Recruiting

2024-518267-35-00 Phase II 1 country Region Sjaelland
StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial Recruiting

2024-517343-31-00 Phase IV 1 country Amsterdam UMC Stichting
Evaluation of the effect of statins, drugs in use to lower cholesterol, in reducing or delaying the progression of Arrhythmogenic Cardiomyop… Recruiting

2024-514643-28-00 Phase II 1 country Centro Cardiologico Monzino S.p.A.
The relationship of cholesterol-lowering drugs with steroid HORMONEs, bile acids, muscle morphology, vitamin D, the immune system and relate… Recruiting

2024-516967-10-00 Phase IV 1 country Medical University Of Vienna
Use of statins in patients with intracerebral hemorrhage Recruiting

2024-511465-11-00 Phase III 1 country Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
Pragmatic clinical trial to assess the utility of SLCO1B1, ABCG2, and CYP2C9 preemtive genotyping and pharmacogenetics training on the incid… Recruiting

2023-506814-31-01 Phase IV 1 country Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa
Atorvastatin in episodic migraine Recruiting

2022-502176-23-01 Phase II 1 country St. Olavs Hospital HF
Atorvastatin in chronic migraine (StainMigChronic) Recruiting

2022-502177-42-02 Phase II 1 country St. Olavs Hospital HF
Measuring Oncological Value of Exercise and Statin (MOVES) Recruiting

2024-515109-24-00 Phase III 1 country Pirkanmaan hyvinvointialue
Post-Operative Atrial Fibrillation after Surgical Aortic Valve Replacement and the influence of HMG-CoA reductase inhibitors Recruiting

2024-511601-34-00 Phase IV 1 country Odense University Hospital

Showing 1–24 of 35 trials

← All drugs A–Z